Research Nester published a report titled Respiratory Inhaler Device Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview of the global respiratory inhaler devicemarket in terms of market segmentation by product, technology, disease indication, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The global respiratory inhaler device market is estimated to garner notable CAGRover the forecast period, i.e., 2022 – 2031. The market is segmented by disease indication into asthma, chronic obstructive pulmonary disease, pulmonary disease, and others. Out of which, the asthma sub-segment is expected to hold the largest share in the global respiratory inhaler device market on account of the consistently rising number of patients with asthma. The data published by the World Health Organization states that asthma affected 262 million people in 2019 and caused 455,000 deaths worldwide.


The global respiratory inhaler device market is expected to grow significantly during the forecast period on the back of rising cases of chronic obstructive pulmonary diseases.  Additionally, the growing cases of bronchitis are also a major factor driving the growth of the global respiratory inhaler devicemarket during the forecast period. The data published by the National Center for Biotechnology Information states that 5% of adults in the U.S. suffer from acute bronchitis every year. Apart from this the rising cases of the common cold are also expected to grow the global respiratory inhaler device market during the forecast period. The respiratory inhaler devices are highly effective in providing relief to patients with the common cold.

Regionally, the global respiratory inhaler device market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America region is estimated to witness modest growth over the forecast period on the back of the presence of well-developed healthcare infrastructure.Furthermore, the Centers for Disease Control and Prevention states that chronic obstructive pulmonary diseases (COPD) affect more than 15 million Americans. On account of this, the global respiratory inhaler device market is projected to witness remarkable growth during the forecast period. The Asia Pacific region is also estimated to witness remarkable growth during the forecast period on account ofthe large number of people suffering from respiratory diseases.  

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Rising Cases of Common Cold likely to Boost the Market Growth

The data released by American Lung Association states that young children suffer from an average of 6 to 8 colds per year.

The rising cases of the common cold are expected to boost the global respiratory inhaler devicemarket growth during the forecast period. The respiratory inhalers help in relaxing the muscles of the patients and make it easier to breathe, which is the reason the global respiratory inhaler devicemarket is estimated to grow during the forecast period.

However, associated side effects, such as, allergiesare expected to operate as a key restraint to the growth of the global respiratory inhaler devicemarket over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global respiratory inhaler devicemarketwhich includes company profiling ofTeva Pharmaceuticals Industries Ltd, Beximco Pharmaceuticals Ltd., Omron Healthcare Europe B.V, Boehringer Ingelheim International GmbH, Merck & Co., Inc., GlaxoSmithKline plc., Cipla Inc., Koninklijke Philips N.V., PARI GmbH, and AstraZeneca plc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global respiratory inhaler devicemarketthat will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.   

You need to be a member of Global Risk Community to add comments!

Join Global Risk Community

Votes: 0
Email me when people reply –

[Free COVID-19 Framework] What's the path to recovery look like?

We created a free presentation (attached), which discusses both global and organizational impacts of the COVID-19 pandemic, along with critical actions organizations should take immediately. This presentation introduces a framework that helps regions and organizations navigate a path to recovery via 9 potential scenarios. These scenarios capture outcomes related to GDP impact, public health response, and economic policies. The presentation also breaks down 6 immediate and critical actions…

Read more…
4 Replies · Reply by Steve Diaz Jul 8
Views: 194

If risk management is about decision making, are current risk management solutions irrelevant?

Now that the updated COSO and ISO risk management standards emphasize a connection to enterprise objectives and decision making, does this mean ERM and GRC solutions focused on risk registers and regulatory compliance are missing the true value of risk management?Will current risk management solutions evolve to integrate more decision support functionality or will standalone prescriptive analytics and other technology solutions take a more prominent role in enabling risk-informed…

Read more…
3 Replies
Views: 119

A question related to classification of instruments between trading and banking book.

We have an interesting question from one of our members.       "We usually perform OTC FX transactions with clients backed-to-back on the market (with Banks). Now we are going to perform a FX swap (i.e. Spot + forward) JPY/EUR for the Bank account for 1 week at the longest. The purpose is to get EUR place @ CB for LCR compliance purpose (no trading purposes). Bank's Management think that this should be considered as a trading position and therefore be classified within the Bank's trading book.…

Read more…
4 Replies
Views: 250

Plunging oil prices: curse or blessing in disguise?

The recent sudden crash of oil prices has had a major impact on the world economy, leading to many troubled faces in the international arena. The Russians fear the effects of yet another powerful hit on their economy, Venezuela seems to be considering default and the Americans are weary of the consequences for its young and emerging shale oil industry. And then you have the Middle East, where the smallest match is enough to ignite the largest fire. But are these worries really justified or…

Read more…
1 Reply
Views: 86

Introducing the Global Risk Series - Book 1 Risk Management How Tos

Dear GlobalRisk Community member, Our community’s mission is to foster business, networking and educational explorations among members. Learn from some of the top experts in the industry as they clearly explain how to approach the most important Risk management concepts. Check out their expert tips and use the link at the end of each article to navigate back to the website to leave your comment or ask a question. Some of the topics include: How do you Explain Risk Appetite?  How to Prepare a…

Read more…
14 Replies · Reply by Boris Agranovich Sep 12, 2022
Views: 803

    About Us

    The GlobalRisk Community is a thriving community of risk managers and associated service providers. Our purpose is to foster business, networking and educational explorations among members. Our goal is to be the worlds premier Risk forum and contribute to better understanding of the complex world of risk.

    Business Partners

    For companies wanting to create a greater visibility for their products and services among their prospects in the Risk market: Send your business partnership request by filling in the form here!